LoginSignup
Abbott logo

Abbott

Stock
Stock
ISIN: US0028241000
Ticker: ABT
US0028241000
ABT

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Abbott has so far distributed $0.59 in 2025. The next dividend will be paid on 15.05.2025

$0.966

CHART BY

Frequently asked questions

What is Abbott's market capitalization?

The market capitalization of Abbott is $225.27B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Abbott's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Abbott is 16.82. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Abbott?

Abbott's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $7.723. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Abbott's stock?

Currently, 29 analysts cover Abbott's stock, with a consensus target price of $142.90. Analyst ratings provide insights into the stock's expected performance.

What is Abbott's revenue over the trailing twelve months?

Over the trailing twelve months, Abbott reported a revenue of $42.34B.

Is Abbott paying dividends?

Yes, Abbott is paying dividends. The next payment is scheduled for 15.05.2025, with an expected amount of .

How many employees does Abbott have, and what sector and industry does it belong to?

Abbott employs approximately 114,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of Abbott's shares?

The free float of Abbott is 1.72B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$225.27B
EPS (TTM) 
$7.723
Free Float 
1.72B
P/E ratio (TTM) 
16.82
Revenue (TTM) 
$42.34B

Pricing

1D span
$129.15$134.06
52W span
$99.71$141.01

Analyst Ratings

The price target is $142.90 and the stock is covered by 29 analysts.

Buy

19

Hold

9

Sell

1

Information

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Employees
114,000
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US0028241000
Primary Ticker
ABT

Knockouts

LSX Data · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin